Comsentimento enriches and connects data to improve care and accelerate cancer research.
Comsentimento has raised $286K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2022.
Comsentimento's investors include Incubate Fund, Aimorés Investments.
Comsentimento is headquartered in São Paulo, Brazil.
Comsentimento enriches and connects data to improve care and accelerate cancer research.
Comsentimento is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Comsentimento — Funding & Investors." VCBacked, December 9, 2022, https://www.vcbacked.co/company/comsentimento. Accessed September 29, 2026.
VCBacked. (2022). Comsentimento — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/comsentimento
{{cite web |title=Comsentimento — Funding & Investors |url=https://www.vcbacked.co/company/comsentimento |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated